National Institutes of Health · USA

Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases

Vorankündigung — noch nicht geöffnet

National Institutes of Health plant 4 Förderungen mit 300.000 $ – 600.000 $ pro Projekt. Dies ist eine Vorankündigung: Der Fördergeber hat die Ausschreibung angekündigt, sie ist aber noch nicht geöffnet, voraussichtliche Frist 4. März 2027. Antragsberechtigte Gruppen laut Quelle: Public housing authorities/Indian housing authorities, Special district governments, State governments und 12 weitere.

Frist: Voraussichtlich 4. März 2027 (noch nicht bestätigt)
Fördersumme: 300.000 $ – 600.000 $ pro Projekt
Förderquote: Kein Pflicht-Eigenanteil angegeben; Förderquote nicht angegeben
Erwartete Förderungen: 4
Eigenanteil: Nicht erforderlich
Wahrscheinliche Antragstellende: Öffentliche Stellen, Hochschulen & Forschung, KMU / Start-ups, Unternehmen, Gemeinnützige Aus Quellkategorien oder Programmregeln; maßgeblich ist die Ausschreibung.
Fördergeber: National Institutes of Health
Referenz: PAR-27-109
Assistance Listing (USA): 93.846 Arthritis, Musculoskeletal and Skin Diseases Research
Zuletzt geprüft: 15. November 2026

Offizielle Ausschreibung öffnen ↗

Die offiziellen Beschreibungen sind in der Sprache des Fördergebers (meist Englisch); Zusammenfassung und Eckdaten auf dieser Seite sind auf Deutsch.

Über diese Ausschreibung

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for Exploratory Clinical Trials Grants Program in the mission areas of NIAMS. The goal of the NIAMS clinical trial program is to support research leading to the prevention or reduction of symptoms and improve outcomes and function in patients with rheumatic, musculoskeletal, or skin conditions or diseases. The purpose of the Exploratory Clinical Trials Grants Program is to foster clinical trials that will lead to clinically meaningful improvements in prevention, diagnosis, or treatment of these conditions or diseases.

This Exploratory Clinical Trials Grants Program is designed to facilitate the execution of short-term, interventional studies. The Program is intended to support a range of exploratory studies, from proof-of-concept/first in human to Phase I and Phase II clinical trials. Such studies must meet the NIH definition of a clinical trial and be feasible within the time and budget constraints of this NOFO. A high priority is the use of such studies to stimulate the translation of promising research developments from laboratory, preclinical, and early human testing into clinical practice.

Vollständigen Text lesen

Examples of research areas of interest include, but are not limited to:

• Conducting early-stage clinical trials, such as but not limited to; first in human, dose-finding or escalation/tolerability/safety/efficacy studies with drugs, biologics, devices, behavioral interventions, and/or physical therapy for treatment of arthritis, musculoskeletal, or skin conditions or diseases.

• Clinical trials to provide data required to support a future, more robust clinical trial whose aim is to help establish the safety and efficacy or effectiveness of an intervention.

• Clinical trials in rare diseases where the number of potential study participants is limited.

• Clinical trials to determine the predictive value of a potential biomarker.

Wer kann sich bewerben?

Public housing authorities/Indian housing authorities
Special district governments
State governments
City or township governments
Public and State controlled institutions of higher education
For profit organizations other than small businesses
Native American tribal governments (Federally recognized)
Independent school districts
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Private institutions of higher education
County governments

Antragstellerkategorien sind nur ein Ausgangspunkt. Über die Antragsberechtigung entscheidet die offizielle Ausschreibung.

Themen

Health

So bewerben Sie sich

Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
For NIH: the organisation and the principal investigator also need eRA Commons accounts; applications are usually submitted through Grants.gov (for example with ASSIST).
Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply: Not stated in the call text we hold — check the official page
Company stage: Not stated in the call text we hold — check the official page
Single applicant or consortium: Not stated in the call text we hold — check the official page
Where applicants must be based: Not stated in the call text we hold — check the official page
Where to apply: Not stated in the call text we hold — check the official page

Kontakt

National Institute of Arthritis and Musculoskeletal and Skin Diseases · NIAMS_NOFOs@mail.nih.gov · Please contact via e-mail.

Offizielle Quellen

Offizielle Ausschreibungsseite

Die Angaben auf dieser Seite stammen aus der offiziellen Quelle und wurden zuletzt am 15. November 2026 geprüft. Maßgeblich sind immer die Unterlagen des Fördergebers einschließlich späterer Änderungen.